Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by canadapieton Apr 19, 2022 11:26am
114 Views
Post# 34613259

RE:RE:Volume

RE:RE:Volume
:-).........
Would not compare those 2 very different companies, but as an investor i know where i earned the most.....!!! ( btw, am back in at average of 50 EUR). 
Do not forget the massive amount of money they still have in the bank, the CEO (ex-) did a tremendous deal with GILD, something TH's management can learn a lot of....!!!! 

But will hold the rest of TH after selling those 10.000, and wait and hope for that wonderful next phase 1b.....
I need the money for the purchase of another "beauty" promising biotech.......:-) 



RE:Volume
Sort of like Galapagos....;-)  You can easily sell that amount, just hit bids. Seems everyone is just waiting for further news on RP2D, PK/PD data hints and starting the larger basket trial. Moving this pipeline asset into it's next more interesting phase.   Getting some initial in-depth facts in order to assess probability of success in next phase is probably a good idea, not a bad one. 

canadapiet wrote:HELP!!! 

Can't sell my 10.000 shares........

What a freaking joke this became after all those years of hope, eternal hope! 

<< Previous
Bullboard Posts
Next >>